Key result
Elevated inflammatory markers are linked to increased cardiovascular and non-cardiovascular complications in diabetes.
Why the study?
Insulin resistance and vascular complications of diabetes involve inflammation, endothelial dysfunction, and oxidative stress, with unclear clinical implications of inflammatory markers and treatments in type 2 diabetes.
Design
Review of clinical studies on inflammation and type 2 diabetes
Authors
Loading...
Antihyperglycemic interventions may mitigate inflammatory vascular processes in diabetes; leaves open whether pathway-specific targeting improves outcomes.
This review highlights the role of inflammation and endothelial dysfunction in the vascular complications of diabetes, suggesting inflammatory markers as predictors and potential therapeutic targets.
Kampoli et al. (2011) conducted a review in Type 2 Diabetes Mellitus. Inflammation markers, including CRP, IL-6, TNF-alpha, and adhesion molecules, are associated with cardiovascular and non-cardiovascular complications of type 1 and type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: